Evidence map›Paper›PMID 34928724›Full record

ArticleCancer control : journal of the Moffitt Cancer Center

Examining More Lymph Nodes May Improve the Prognosis of Patients With Right Colon Cancer: Determining the Optimal Minimum Lymph Node Count.

Wentao Wu, Daning Li, Wen Ma, Shuai Zheng, Didi Han, Fengshuo Xu, Hong Yan, Jun Lyu

Abstract read
In one paragraph

Article in Cancer control : journal of the Moffitt Cancer Center. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Prognostic factors of non-metastatic right colon adenocarcinoma: A multicentre retrospective analysis from the ATCCR database.Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland · 2026
    Observational
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Wentao WuDepartment of Clinical Research, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Daning LiSchool of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China.
Wen MaDepartment of Clinical Research, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Shuai ZhengDepartment of Clinical Research, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Didi HanDepartment of Clinical Research, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Fengshuo XuDepartment of Clinical Research, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Hong YanSchool of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China.
Jun LyuDepartment of Clinical Research, The First Affiliated Hospital of Jinan University, Guangzhou, China.ORCID https://orcid.org/0000-0002-2237-8771

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe objective is to determine the optimal minimum lymph node examination number for right colon cancer (RCC) patients.

methodsWe comprehensively analysed the Surveillance, Epidemiology and End Results database data from 2004 to 2016 to determine the 13-year trend in the number of lymph nodes examined among 108,703 left colon cancer and 165,937 RCC patients. 133,137 RCC patients eligible for inclusion were used to determine the optimal minimum for lymph node examination. We used restricted cubic splines to analyse the dose-response relationship between the number of lymph nodes examined and prognosis. X-tiles and decision trees were used to determine the optimal cutoff for the number of lymph nodes based on the survival outcomes of patients with RCC. The Kaplan-Meier method and COX model were used to estimate the overall survival and independent prognostic factors, and a prediction model was constructed. The C-index, calibration curve, net reclassification improvement and integrated discrimination improvement were used to determine the predictive performance of the model, and decision curve analysis was used to evaluate the benefits.

resultsLymph node examinations were common among colon cancer patients over the 13-year study period. It is generally agreed that at least 12 lymph nodes must be examined to ensure proper dissection and accurate staging of RCC; however, the optimal number of lymph nodes to be examined is controversial. The dose-response relationship indicated that 12 was not the optimal minimum number of lymph nodes for RCC patients. X-tile and survival decision-tree analysis indicated that 20 nodes was the optimal number. Survival analysis indicated that <20 nodes examined was a risk factor for poor prognosis, and the classification performance was superior for 20 nodes compared to 12 nodes.

conclusionLymph node examination in RCC patients should be altered. Our research suggests that a 20-node measure may be more suitable for RCC patients.

Indexed as

AgedColonic NeoplasmsFemaleHumansKaplan-Meier EstimateLymphatic MetastasisLymph Node ExcisionLymph NodesMaleMiddle AgedNeoplasm StagingPrognosisProportional Hazards ModelsRisk FactorsSEER Programdose-response relationshiplymph node examinationoptimal minimum nodeprognosis nomogramright colon cancer

Identifiers

PMID34928724
PMCPMC8728779

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.